PF-655

Quark Pharma extends pact with Pfizer to develop compounds containing Silence’s AtuRNAi
Pharmabiz
Sat, 05/5/12 - 04:38 pm
Pfizer
Quark Pharmaceuticals
Silence Therapeutics
PF-655
Open-Angle Glaucoma
diabetic macular oedema
AtuRNAi